Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma (TBPH) Misses Q1 EPS by 5c, Beats on Revenue

May 8, 2025 4:34 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q1 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $15.14 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More